Table of contents.
- Published in:
- Cytometry. Part B, 2016, v. 90, n. 1, p. 3, doi. 10.1002/cyto.b.21282
- Publication type:
- Article
Works matching IS 15524949 AND DT 2016 AND VI 90 AND IP 1
Results: 18
1
2
Publication schedule for 2016.
- Published in:
- Cytometry. Part B, 2016, v. 90, n. 1, p. 5, doi. 10.1002/cyto.b.21283
- Publication type:
- Article
3
Announcing the 2015 Wallace H. Coulter distinguished lecture award recipient.
- Published in:
- Cytometry. Part B, 2016, v. 90, n. 1, p. 6, doi. 10.1002/cyto.b.21284
- Publication type:
- Article
4
Editors' annual best original paper award.
- Published in:
- Cytometry. Part B, 2016, v. 90, n. 1, p. 7, doi. 10.1002/cyto.b.21285
- Publication type:
- Article
5
Principles of minimal residual disease detection for hematopoietic neoplasms by flow cytometry.
- Published in:
- Cytometry. Part B, 2016, v. 90, n. 1, p. 47, doi. 10.1002/cyto.b.21239
- By:
- Publication type:
- Article
6
Measuring disease levels in myeloma using flow cytometry in combination with other laboratory techniques: Lessons from the past 20 years at the Leeds Haematological Malignancy Diagnostic Service.
- Published in:
- Cytometry. Part B, 2016, v. 90, n. 1, p. 54, doi. 10.1002/cyto.b.21271
- By:
- Publication type:
- Article
7
Assessment of minimal residual disease in myeloma and the need for a consensus approach.
- Published in:
- Cytometry. Part B, 2016, v. 90, n. 1, p. 21, doi. 10.1002/cyto.b.21272
- By:
- Publication type:
- Article
8
Better therapy requires better response evaluation: Paving the way for minimal residual disease testing for every myeloma patient.
- Published in:
- Cytometry. Part B, 2016, v. 90, n. 1, p. 14, doi. 10.1002/cyto.b.21273
- By:
- Publication type:
- Article
9
Flow cytometry quality requirements for monitoring of minimal disease in plasma cell myeloma.
- Published in:
- Cytometry. Part B, 2016, v. 90, n. 1, p. 40, doi. 10.1002/cyto.b.21276
- By:
- Publication type:
- Article
10
Multiple myeloma: New surface antigens for the characterization of plasma cells in the era of novel agents.
- Published in:
- Cytometry. Part B, 2016, v. 90, n. 1, p. 81, doi. 10.1002/cyto.b.21279
- By:
- Publication type:
- Article
11
Introduction to multiple myeloma special issue: The flow cytometric detection of minimal residual disease.
- Published in:
- Cytometry. Part B, 2016, v. 90, n. 1, p. 9, doi. 10.1002/cyto.b.21342
- Publication type:
- Article
12
Contribution photo.
- Published in:
- Cytometry. Part B, 2016, v. 90, n. 1, p. 11, doi. 10.1002/cyto.b.21346
- Publication type:
- Article
13
Dr. Carleton Colburn Stewart july 13th, 1940 - august 24, 2015 tribute article.
- Published in:
- Cytometry. Part B, 2016, v. 90, n. 1, p. 2, doi. 10.1002/cyto.b.21347
- Publication type:
- Article
14
Consensus guidelines on plasma cell myeloma minimal residual disease analysis and reporting.
- Published in:
- Cytometry. Part B, 2016, v. 90, n. 1, p. 31, doi. 10.1002/cyto.b.21228
- By:
- Publication type:
- Article
15
Consensus guidelines for myeloma minimal residual disease sample staining and data acquisition.
- Published in:
- Cytometry. Part B, 2016, v. 90, n. 1, p. 26, doi. 10.1002/cyto.b.21249
- By:
- Publication type:
- Article
16
Immunophenotype of normal vs. myeloma plasma cells: Toward antibody panel specifications for MRD detection in multiple myeloma.
- Published in:
- Cytometry. Part B, 2016, v. 90, n. 1, p. 61, doi. 10.1002/cyto.b.21265
- By:
- Publication type:
- Article
17
Regulatory perspective on minimal residual disease flow cytometry testing in multiple myeloma.
- Published in:
- Cytometry. Part B, 2016, v. 90, n. 1, p. 73, doi. 10.1002/cyto.b.21268
- By:
- Publication type:
- Article
18
Utility of CD54, CD229, and CD319 for the identification of plasma cells in patients with clonal plasma cell diseases.
- Published in:
- Cytometry. Part B, 2016, v. 90, n. 1, p. 91, doi. 10.1002/cyto.b.21269
- By:
- Publication type:
- Article